Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
64
SURDF Quote, Financials, Valuation and Earnings
Last price:
$31.59
Seasonality move
:
-2%
Day range:
$31.59 - $31.59
52-week range:
$27.35 - $38.11
Dividend yield:
1.41%
P/E ratio:
11.53x
P/S ratio:
2.17x
P/B ratio:
1.00x
Volume:
--
Avg. volume:
81
1-year change:
3.02%
Market cap:
$15B
Revenue:
$6.7B
EPS (TTM):
$2.74
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.3B | $8.7B | $8.4B | $7B | $6.7B | |
| Revenue Growth (YoY) | 2.14% | -7.19% | -3.31% | -16.82% | -3.66% | |
| Cost of Revenues | $6.4B | $5.9B | $5.7B | $4.6B | $4.4B | |
| Gross Profit | $3B | $2.7B | $2.7B | $2.3B | $2.3B | |
| Gross Profit Margin | 31.74% | 31.38% | 32.19% | 33.46% | 34.35% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $170.3M | $87.1M | $81.6M | $68M | $64.8M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $803.6M | $647.7M | $610.7M | $541.9M | $538.3M | |
| Operating Income | $2.2B | $2.1B | $2.1B | $1.8B | $1.8B | |
| Net Interest Expenses | $170.5M | $170.2M | $159.5M | $126.8M | $115.5M | |
| EBT. Incl. Unusual Items | $1.9B | $2B | $1.9B | $1.7B | $1.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $596.3M | $650.6M | $607.5M | $506.6M | $527.3M | |
| Net Income to Company | $1.9B | $2B | $1.9B | $1.7B | $1.8B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B | |
| Basic EPS (Cont. Ops) | $2.74 | $2.81 | $2.83 | $2.53 | $2.59 | |
| Diluted EPS (Cont. Ops) | $2.74 | $2.81 | $2.83 | $2.53 | $2.59 | |
| Weighted Average Basic Share | $473.9M | $473.9M | $473.9M | $473.9M | $473.9M | |
| Weighted Average Diluted Share | $473.9M | $473.9M | $473.9M | $473.9M | $473.9M | |
| EBITDA | $2.5B | $2.7B | $2.6B | $2.3B | $2.4B | |
| EBIT | $2.1B | $2.2B | $2.1B | $1.8B | $1.9B | |
| Revenue (Reported) | $9.3B | $8.7B | $8.4B | $7B | $6.7B | |
| Operating Income (Reported) | $2.2B | $2.1B | $2.1B | $1.8B | $1.8B | |
| Operating Income (Adjusted) | $2.1B | $2.2B | $2.1B | $1.8B | $1.9B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.3B | $1.9B | $1.8B | $2B | |
| Revenue Growth (YoY) | -3.48% | -22.09% | -17.85% | -1.84% | 9.78% | |
| Cost of Revenues | $2B | $1.5B | $1.2B | $1.2B | $1.3B | |
| Gross Profit | $933.4M | $803.9M | $682.3M | $685.8M | $739.7M | |
| Gross Profit Margin | 31.79% | 35.14% | 36.3% | 37.18% | 36.53% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21.3M | $23.2M | $15.3M | $18.4M | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $164.2M | $154.9M | $114.3M | $116.3M | $110.3M | |
| Operating Income | $769.1M | $649M | $568M | $569.5M | $629.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $890M | $653.3M | $584.8M | $596.8M | $669.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $281.4M | $204M | $176.6M | $182.2M | $190.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $608.6M | $449.3M | $408.2M | $414.5M | $478.2M | |
| Basic EPS (Cont. Ops) | $1.28 | $0.95 | $0.86 | $0.87 | $1.01 | |
| Diluted EPS (Cont. Ops) | $1.28 | $0.95 | $0.86 | $0.87 | $1.01 | |
| Weighted Average Basic Share | $473.9M | $473.9M | $473.9M | $473.9M | $473.9M | |
| Weighted Average Diluted Share | $473.9M | $473.9M | $473.9M | $473.9M | $473.9M | |
| EBITDA | $933.1M | $694.9M | $618.1M | $629.8M | $699.7M | |
| EBIT | $933.1M | $694.9M | $618.1M | $629.8M | $699.7M | |
| Revenue (Reported) | $2.9B | $2.3B | $1.9B | $1.8B | $2B | |
| Operating Income (Reported) | $769.1M | $649M | $568M | $569.5M | $629.4M | |
| Operating Income (Adjusted) | $933.1M | $694.9M | $618.1M | $629.8M | $699.7M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.2B | $8B | $8B | $6.9B | $6.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.3B | $5.4B | $5.4B | $4.6B | $4.5B | |
| Gross Profit | $3B | $2.6B | $2.6B | $2.3B | $2.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $135.9M | $89M | $73.6M | $71.1M | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $772.8M | $638.1M | $569.2M | $543.5M | $530.4M | |
| Operating Income | $2.2B | $1.9B | $2B | $1.8B | $1.8B | |
| Net Interest Expenses | $163.1M | $173.4M | $143.6M | $120.7M | $110M | |
| EBT. Incl. Unusual Items | $2B | $1.7B | $1.9B | $1.7B | $1.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $653M | $570.6M | $582.9M | $512.1M | $539.5M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.4B | $1.2B | $1.3B | $1.2B | $1.3B | |
| Basic EPS (Cont. Ops) | $2.95 | $2.47 | $2.76 | $2.55 | $2.74 | |
| Diluted EPS (Cont. Ops) | $2.95 | $2.47 | $2.76 | $2.55 | $2.74 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $2.2B | $1.9B | $2B | $1.8B | $2B | |
| EBIT | $2.2B | $1.9B | $2B | $1.8B | $2B | |
| Revenue (Reported) | $9.2B | $8B | $8B | $6.9B | $6.9B | |
| Operating Income (Reported) | $2.2B | $1.9B | $2B | $1.8B | $1.8B | |
| Operating Income (Adjusted) | $2.2B | $1.9B | $2B | $1.8B | $2B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.3B | $1.9B | $1.8B | $2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2B | $1.5B | $1.2B | $1.2B | $1.3B | |
| Gross Profit | $933.4M | $803.9M | $682.3M | $685.8M | $739.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $21.3M | $23.2M | $15.3M | $18.4M | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $164.2M | $154.9M | $114.3M | $116.3M | $110.3M | |
| Operating Income | $769.1M | $649M | $568M | $569.5M | $629.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $890M | $653.3M | $584.8M | $596.8M | $669.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $281.4M | $204M | $176.6M | $182.2M | $190.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $608.6M | $449.3M | $408.2M | $414.5M | $478.2M | |
| Basic EPS (Cont. Ops) | $1.28 | $0.95 | $0.86 | $0.87 | $1.01 | |
| Diluted EPS (Cont. Ops) | $1.28 | $0.95 | $0.86 | $0.87 | $1.01 | |
| Weighted Average Basic Share | $473.9M | $473.9M | $473.9M | $473.9M | $473.9M | |
| Weighted Average Diluted Share | $473.9M | $473.9M | $473.9M | $473.9M | $473.9M | |
| EBITDA | $933.1M | $694.9M | $618.1M | $629.8M | $699.7M | |
| EBIT | $933.1M | $694.9M | $618.1M | $629.8M | $699.7M | |
| Revenue (Reported) | $2.9B | $2.3B | $1.9B | $1.8B | $2B | |
| Operating Income (Reported) | $769.1M | $649M | $568M | $569.5M | $629.4M | |
| Operating Income (Adjusted) | $933.1M | $694.9M | $618.1M | $629.8M | $699.7M | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.8B | $1.7B | $1.2B | $1.4B | $686.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $161M | $169.6M | $190.8M | $285.5M | $208.4M | |
| Inventory | $6B | $5.8B | $5.8B | $5.9B | $5.8B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $503.3M | $619.5M | $445.8M | $552.6M | $388.1M | |
| Total Current Assets | $8.5B | $8.3B | $7.7B | $8.2B | $7.1B | |
| Property Plant And Equipment | $35.3B | $37B | $34.3B | $34B | $30.3B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $532.6M | $565.8M | $524.3M | $475M | $454.7M | |
| Other Long-Term Assets | $317.4M | $298.6M | $278.4M | $313.9M | $286M | |
| Total Assets | $49.2B | $51.4B | $47.6B | $47.8B | $44.1B | |
| Accounts Payable | $336.7M | $223.9M | $346.6M | $218.1M | $232.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.8B | $2B | $2B | $2.1B | $1.6B | |
| Total Current Liabilities | $5.8B | $6B | $5.2B | $6.3B | $5.6B | |
| Long-Term Debt | $28.6B | $28.9B | $26.6B | $25.8B | $22.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $37.2B | $37.8B | $34.2B | $34.3B | $30.6B | |
| Common Stock | $1.1B | $1.1B | $1B | $921.7M | $811.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $12B | $13.6B | $13.4B | $13.5B | $13.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $12B | $13.6B | $13.4B | $13.5B | $13.5B | |
| Total Liabilities and Equity | $49.2B | $51.4B | $47.6B | $47.8B | $44.1B | |
| Cash and Short Terms | $1.8B | $1.7B | $1.2B | $1.4B | $686.5M | |
| Total Debt | $31.8B | $32.3B | $29.2B | $29.6B | $26.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6B | $1.6B | $1.3B | $1.6B | $519M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $106.4M | $119.5M | $117.1M | $132.7M | $131.7M | |
| Inventory | $5.7B | $5.7B | $4.9B | $5.1B | $5.8B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $520.1M | $527M | $418.6M | $385.3M | $453.1M | |
| Total Current Assets | $7.9B | $8B | $6.7B | $7.2B | $6.9B | |
| Property Plant And Equipment | $37.4B | $37B | $29.1B | $30.4B | $32.5B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $588.5M | $563.1M | $444.2M | $426M | $503.4M | |
| Other Long-Term Assets | $313.3M | $278.3M | $260.5M | $299.9M | $323.6M | |
| Total Assets | $51B | $51.2B | $40.5B | $43.9B | $46.5B | |
| Accounts Payable | $140.8M | $188.8M | $115.4M | $131.6M | $176.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.5B | $1.7B | $1.4B | $1.5B | $1.4B | |
| Total Current Liabilities | $5.9B | $5.4B | $3.9B | $6.7B | $5.6B | |
| Long-Term Debt | $28.8B | $28.8B | $22.8B | $22B | $23.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $37.6B | $37B | $28.6B | $30.8B | $31.5B | |
| Common Stock | $1.2B | $1.1B | $850.1M | $822.1M | $859.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $13.4B | $14.3B | $11.9B | $13.1B | $15B | |
| Total Liabilities and Equity | $51B | $51.2B | $40.5B | $43.9B | $46.5B | |
| Cash and Short Terms | $1.6B | $1.6B | $1.3B | $1.6B | $519M | |
| Total Debt | $32.6B | $31.9B | $24.9B | $26.7B | -- | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.9B | $2B | $1.9B | $1.7B | $1.8B | |
| Depreciation & Amoritzation | $450.6M | $545.4M | $540.2M | $478.7M | $506.7M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $42.7M | -$11.2M | -$40.7M | -$109.3M | $45M | |
| Change in Inventories | $430.3M | $68.9M | -$430.5M | -$410.7M | -$508.2M | |
| Cash From Operations | $2.1B | $2.1B | $1.7B | $1.2B | $1.6B | |
| Capital Expenditures | $2.5B | $3.4B | $1.6B | $3.3B | $1.3B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.7B | -$3.2B | -$1.9B | -$3.6B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -$139.5M | -$169.8M | -$181.5M | -$164.9M | -$187.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.3B | $3B | $2.7B | $3.6B | $2.7B | |
| Long-Term Debt Repaid | -$2.5B | -$1.9B | -$2B | -$1.8B | -$2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.9M | -$2.8M | -$2.2M | -$1.5M | -$1.3M | |
| Cash From Financing | $760.4M | $963M | -$195.2M | $2.6B | -$25.3M | |
| Beginning Cash (CF) | $1.6B | $1.8B | $1.7B | $1.1B | $1.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $211.5M | -$81.6M | -$346.8M | $228.6M | -$570.4M | |
| Ending Cash (CF) | $1.8B | $1.8B | $1.3B | $1.4B | $714.6M | |
| Levered Free Cash Flow | -$367M | -$1.2B | $119.5M | -$2.1B | $302.4M | |
| Period Ending | 2007-03-31 | 2008-03-31 | 2009-03-31 | 2010-03-31 | 2011-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $85.7M | $104.8M | |
| Depreciation & Amoritzation | -- | -- | -- | $52M | $63.9M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -$59.1M | -$25.9M | |
| Change in Inventories | -- | -- | -- | -$192.1M | -$1.2B | |
| Cash From Operations | -- | -- | -- | $512.6M | -$615.8M | |
| Capital Expenditures | -- | -- | -- | $623M | $99.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$525.1M | $139.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $3.3M | $4.7M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $1.7B | $1.9B | |
| Long-Term Debt Repaid | -- | -- | -- | -$711.4M | -$966.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $251M | -$70.9M | |
| Cash From Financing | -- | -- | -- | $585M | $873.1M | |
| Beginning Cash (CF) | -- | -- | -- | $1.1B | $1.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$3.1M | $308.2K | |
| Additions / Reductions | -- | -- | -- | $572.4M | $396.5M | |
| Ending Cash (CF) | -- | -- | -- | $1.6B | $1.4B | |
| Levered Free Cash Flow | -- | -- | -- | -$110.4M | -$715.5M | |
| Period Ending | 2007-12-31 | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2011-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $1B | -- | |
| Depreciation & Amoritzation | -- | -- | -- | $263.4M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | $839.3K | -- | |
| Change in Inventories | -- | -- | -- | $645.7M | -- | |
| Cash From Operations | -- | -- | -- | $1.3B | -- | |
| Capital Expenditures | -- | -- | $606.3M | $1.7B | $99.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$1.5B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$105.6M | -$111.5M | $4.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $5.3B | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$2.9B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$191M | -- | |
| Cash From Financing | -- | -- | -- | $81.6M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$163.7M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$366.1M | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get SURDF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SURDF
Sector
P/E ratio
11.53x
21.43x
PEG ratio
1.50x
0.19x
P/B ratio
1.00x
0.80x
Price / LTM sales
2.17x
3.51x
Growth Metrics
SURDF
Sector
Revenue growth
9.78%
3.19%
Earnings growth
15.35%
--
Revenue (5-year growth)
-5.99%
3.36%
Earnings forecast
--
$0.16
Profitability
SURDF
Sector
Profitability FY 2023
$2.3B
$211.9M
Return on invested capital
3.2%
1.17%
Return on assets
2.9%
1.05%
Return on equity
9.19%
2.3%
Earnings Date
Last Earnings Date
Jun
24
Next Earnings Date
Dec
23
Estimated Next Earnings Date
Mar
24
Balance Sheet
SURDF
Sector
Total cash
$519M
$76.4M
Short term investments
--
$21.6M
Total assets
$44.1B
$3.5B
Long term debt
--
$1.2B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
